Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lindenbergh PL"'
Autor:
van der Stegen SJC; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lindenbergh PL; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Amsterdam, Amsterdam, the Netherlands., Petrovic RM; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Xie H; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Diop MP; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Alexeeva V; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shi Y; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mansilla-Soto J; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hamieh M; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Eyquem J; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Gladstone-UCSF Institute of Genomic Immunology, Gladstone Institutes, San Francisco, CA, USA., Cabriolu A; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wang X; Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Abujarour R; Fate Therapeutics Inc, San Diego, CA, USA., Lee T; Fate Therapeutics Inc, San Diego, CA, USA., Clarke R; Fate Therapeutics Inc, San Diego, CA, USA., Valamehr B; Fate Therapeutics Inc, San Diego, CA, USA., Themeli M; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Amsterdam, Amsterdam, the Netherlands., Riviere I; Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sadelain M; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA. m-sadelain@ski.mskcc.org.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. m-sadelain@ski.mskcc.org.
Publikováno v:
Nature biomedical engineering [Nat Biomed Eng] 2024 Nov; Vol. 8 (11), pp. 1500.
Autor:
Dobrin A; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lindenbergh PL; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shi Y; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Perica K; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Cell Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Xie H; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Jain N; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chow A; Thoracic Oncology Service, Division of Solid Tumour Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wolchok JD; Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Merghoub T; Department of Pharmacology and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Sadelain M; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA. m-sadelain@ski.mskcc.org.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. m-sadelain@ski.mskcc.org., Hamieh M; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Pediatrics and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Publikováno v:
Nature cancer [Nat Cancer] 2024 May; Vol. 5 (5), pp. 760-773. Date of Electronic Publication: 2024 Mar 19.
Autor:
van der Stegen SJC; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lindenbergh PL; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Amsterdam, Amsterdam, the Netherlands., Petrovic RM; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Xie H; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Diop MP; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Alexeeva V; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shi Y; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mansilla-Soto J; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hamieh M; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Eyquem J; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Gladstone-UCSF Institute of Genomic Immunology, Gladstone Institutes, San Francisco, CA, USA., Cabriolu A; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wang X; Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Abujarour R; Fate Therapeutics Inc, San Diego, CA, USA., Lee T; Fate Therapeutics Inc, San Diego, CA, USA., Clarke R; Fate Therapeutics Inc, San Diego, CA, USA., Valamehr B; Fate Therapeutics Inc, San Diego, CA, USA., Themeli M; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Amsterdam, Amsterdam, the Netherlands., Riviere I; Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sadelain M; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA. m-sadelain@ski.mskcc.org.; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. m-sadelain@ski.mskcc.org.
Publikováno v:
Nature biomedical engineering [Nat Biomed Eng] 2022 Nov; Vol. 6 (11), pp. 1284-1297. Date of Electronic Publication: 2022 Aug 08.
Autor:
Mansilla-Soto J; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA. mansillj@mskcc.org.; Immunology Program, Sloan Kettering Institute, New York, NY, USA. mansillj@mskcc.org., Eyquem J; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, New York, NY, USA.; Department of Medicine, Division of Hemato-Oncology, University of California San Francisco, San Francisco, CA, USA., Haubner S; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, New York, NY, USA., Hamieh M; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, New York, NY, USA., Feucht J; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, New York, NY, USA.; Cluster of Excellence iFIT, University Children's Hospital Tübingen, Tübingen, Germany., Paillon N; Institute Curie, Université PSL, U932 INSERM, Integrative Analysis of T cell Activation Team, Paris, France., Zucchetti AE; Institute Curie, Université PSL, U932 INSERM, Integrative Analysis of T cell Activation Team, Paris, France., Li Z; Microchemistry and Proteomics Core Laboratory, Sloan Kettering Institute, New York, NY, USA., Sjöstrand M; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, New York, NY, USA., Lindenbergh PL; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, New York, NY, USA., Saetersmoen M; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, New York, NY, USA.; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Dobrin A; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, New York, NY, USA., Maurin M; Institute Curie, Université PSL, U932 INSERM, Integrative Analysis of T cell Activation Team, Paris, France., Iyer A; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, New York, NY, USA., Garcia Angus A; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, New York, NY, USA., Miele MM; Microchemistry and Proteomics Core Laboratory, Sloan Kettering Institute, New York, NY, USA., Zhao Z; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, New York, NY, USA., Giavridis T; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, New York, NY, USA.; Mnemo Therapeutics, New York, NY, USA., van der Stegen SJC; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Sloan Kettering Institute, New York, NY, USA., Tamzalit F; Immunology Program, Sloan Kettering Institute, New York, NY, USA., Rivière I; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Huse M; Immunology Program, Sloan Kettering Institute, New York, NY, USA., Hendrickson RC; Microchemistry and Proteomics Core Laboratory, Sloan Kettering Institute, New York, NY, USA.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hivroz C; Institute Curie, Université PSL, U932 INSERM, Integrative Analysis of T cell Activation Team, Paris, France., Sadelain M; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA. m-sadelain@ski.mskcc.org.; Immunology Program, Sloan Kettering Institute, New York, NY, USA. m-sadelain@ski.mskcc.org.
Publikováno v:
Nature medicine [Nat Med] 2022 Feb; Vol. 28 (2), pp. 345-352. Date of Electronic Publication: 2022 Jan 13.
Autor:
Lu H; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts. haihui.lu@novartis.com., Molony RD; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Chen D; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Jang S; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Wolf B; Novartis Institutes for BioMedical Research, Basel, Switzerland., Ewert S; Novartis Institutes for BioMedical Research, Basel, Switzerland., Flaherty M; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Xu F; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Isim S; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Shim Y; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Dornelas C; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Balke N; Novartis Institutes for BioMedical Research, Basel, Switzerland., Leber XC; Novartis Institutes for BioMedical Research, Basel, Switzerland., Scharenberg M; Novartis Institutes for BioMedical Research, Basel, Switzerland., Koelln J; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Choi E; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Ward R; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Johnson J; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Calzascia T; Novartis Institutes for BioMedical Research, Basel, Switzerland., Isnardi I; Novartis Institutes for BioMedical Research, Basel, Switzerland., Williams JA; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Lindenbergh PL; Department of Hematology, Amsterdam University Medical Centers, VUmc, Amsterdam, the Netherlands., van de Donk NWCJ; Department of Hematology, Amsterdam University Medical Centers, VUmc, Amsterdam, the Netherlands., Mutis T; Department of Hematology, Amsterdam University Medical Centers, VUmc, Amsterdam, the Netherlands., Huet H; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Lees E; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Meyer MJ; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2020 Oct; Vol. 19 (10), pp. 2089-2104. Date of Electronic Publication: 2020 Aug 26.
Autor:
Frerichs KA; a Department of Hematology , VU University Medical Center , Amsterdam , The Netherlands., Nagy NA; a Department of Hematology , VU University Medical Center , Amsterdam , The Netherlands., Lindenbergh PL; a Department of Hematology , VU University Medical Center , Amsterdam , The Netherlands., Bosman P; a Department of Hematology , VU University Medical Center , Amsterdam , The Netherlands., Marin Soto J; a Department of Hematology , VU University Medical Center , Amsterdam , The Netherlands., Broekmans M; a Department of Hematology , VU University Medical Center , Amsterdam , The Netherlands., Groen RWJ; a Department of Hematology , VU University Medical Center , Amsterdam , The Netherlands., Themeli M; a Department of Hematology , VU University Medical Center , Amsterdam , The Netherlands., Nieuwenhuis L; a Department of Hematology , VU University Medical Center , Amsterdam , The Netherlands., Stege C; a Department of Hematology , VU University Medical Center , Amsterdam , The Netherlands., Nijhof IS; a Department of Hematology , VU University Medical Center , Amsterdam , The Netherlands., Mutis T; a Department of Hematology , VU University Medical Center , Amsterdam , The Netherlands., Zweegman S; a Department of Hematology , VU University Medical Center , Amsterdam , The Netherlands., Lokhorst HM; a Department of Hematology , VU University Medical Center , Amsterdam , The Netherlands., van de Donk NWCJ; a Department of Hematology , VU University Medical Center , Amsterdam , The Netherlands.
Publikováno v:
Expert review of clinical immunology [Expert Rev Clin Immunol] 2018 Mar; Vol. 14 (3), pp. 197-206. Date of Electronic Publication: 2018 Feb 28.